Lang James Paul
Insider CIK 1703090 · HALO Director · OPRX Director · BIVI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx Corp | A Award | 2026-06-09 | 2026-06-10 | 34,517 | — | $0 | 433,837 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-05-05 | 2026-05-07 | 6,040 | — | $0 | 6,040 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-05-05 | 2026-05-07 | 3,796 | — | $0 | 4,685 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2026-01-05 | 2026-01-09 | 330,500 | — | $0 | 330,500 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2026-01-05 | 2026-01-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award deriv | 2026-01-02 | 2026-01-06 | 1,342 | — | $0 | 1,342 | SEC↗ |
| HALO HALOZYME THERAPEUTICS, INC | A Award | 2026-01-02 | 2026-01-06 | 889 | — | $0 | 889 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2025-06-11 | 2025-06-12 | 9,868 | — | $0 | 399,320 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2025-03-14 | 2025-03-19 | 321,408 | $7.60 | $2.44M | 389,452 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2024-12-20 | 2025-01-07 | 22,690 | — | $0 | 22,690 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2024-11-20 | 2025-01-07 | 61,600 | — | $0 | 61,600 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-06-07 | 2024-06-11 | 13,286 | — | $0 | 68,044 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-06-05 | 2024-06-11 | 10,061 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-06-05 | 2024-06-11 | 10,061 | — | $0 | 54,758 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2023-11-09 | 2023-12-06 | 93,500 | — | $0 | 93,500 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-06-07 | 2023-08-18 | 4,637 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2023-06-07 | 2023-08-18 | 10,061 | — | $0 | 10,061 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-06-07 | 2023-08-18 | 4,637 | — | $0 | 44,697 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-03-30 | 2023-04-03 | 657 | — | $0 | 657 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-03-30 | 2023-04-03 | 657 | — | $0 | 40,060 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-12-30 | 2023-01-04 | 409 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-12-30 | 2023-01-04 | 409 | — | $0 | 39,403 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2022-11-23 | 2023-01-18 | 43,578 | — | $0 | 68,622 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-09-29 | 2022-09-30 | 334 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-09-29 | 2022-09-30 | 334 | — | $0 | 38,994 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2022-08-19 | 2022-08-23 | 6,000 | $16.45 | $98.7K | 38,660 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-06-09 | 2022-06-13 | 4,637 | — | $0 | 4,637 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2022-04-05 | 2022-04-25 | 127,900 | — | $0 | 127,900 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-03-30 | 2022-04-01 | 657 | — | $0 | 657 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-12-30 | 2022-01-03 | 409 | — | $0 | 743 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-09-29 | 2021-10-01 | 334 | — | $0 | 334 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2021-06-30 | 2021-06-30 | 407 | — | $0 | 32,660 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2021-03-31 | 2021-04-02 | 539 | — | $0 | 32,253 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-12-31 | 2021-01-20 | 802 | — | $0 | 31,714 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2020-12-18 | 2021-03-04 | 99,000 | $13.91 | $1.38M | 120,988 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-09-30 | 2021-01-20 | 1,183 | — | $0 | 30,912 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-06-30 | 2020-07-02 | 1,937 | — | $0 | 29,729 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-03-30 | 2020-03-31 | 2,784 | — | $0 | 27,792 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-01-03 | 2020-01-07 | 2,084 | — | $0 | 25,008 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2019-09-30 | 2019-10-02 | 2,084 | — | $0 | 22,924 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2019-03-29 | 2019-03-29 | 2,084 | — | $0 | 14,585 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2019-01-02 | 2019-02-05 | 200,000 | $0.04 | $8.0K | 450,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2018-10-08 | 2018-10-12 | 2,084 | — | $0 | 12,501 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2018-07-03 | 2018-11-01 | 20,000 | $1.50 | $30.0K | 20,000 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2018-07-02 | 2018-11-01 | 2,000,000 | $0.02 | $40.0K | 2,548,485 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2018-06-29 | 2018-07-03 | 2,084 | — | $0 | 10,417 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2018-01-19 | 2018-08-15 | 100,000 | $0.10 | $10.0K | 548,485 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2018-01-10 | 2018-01-12 | 6,250 | — | $0 | 25,000 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2018-01-02 | 2018-08-15 | 166,667 | $0.15 | $25.0K | 448,485 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2018-01-02 | 2018-08-15 | 166,667 | $0.15 | $25.0K | 530,303 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2018-01-02 | 2018-08-15 | 200,000 | $0.15 | $30.0K | 730,303 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2017-09-29 | 2017-10-02 | 6,250 | — | $0 | 18,750 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2017-07-28 | 2018-08-15 | 56,818 | $0.60 | $34.1K | 281,818 | SEC↗ |
| BIVI BIOVIE INC. | A Award | 2017-07-28 | 2018-08-15 | 113,636 | $0.22 | $25.0K | 363,636 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2017-06-30 | 2017-06-30 | 6,250 | — | $0 | 12,500 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2017-03-31 | 2017-04-06 | 6,250 | — | $0 | 6,250 | SEC↗ |
| BIVI BIOVIE INC. | A Award deriv | 2016-12-08 | 2018-08-15 | 100,000 | $0.21 | $21.0K | 225,000 | SEC↗ |